Literature DB >> 4211799

An improved test for Haemophilus influenzae precipitins in the serum of patients with chronic respiratory disease.

J L Davies, C R Laughton, J R May.   

Abstract

The detection of antibacterial precipitins in the serum of patients with chronic lower respiratory infections has been shown to be of great value in the assessment of pathogenicity of the corresponding bacterial species in the sputum. The test used hitherto, however, is time-consuming and cumbersome owing to the need to distinguish, by immunoelectrophoresis, between antibodies specific to the organism in question and those which react with antigens common to various Gram-negative species. A method has now been devised for the preparation of an extract of Haemophilus influenzae containing species-specific antigens only. Use of this extract obviates the need for immuno-electrophoresis and improves the sensitivity of the test.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4211799      PMCID: PMC478099          DOI: 10.1136/jcp.27.4.265

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  A study of Hemophilus influenzae precipitins in the serum of working men in relation to smoking habits, bronchial infection, and airway obstruction.

Authors:  J R May; R Peto; C M Tinker; C M Fletcher
Journal:  Am Rev Respir Dis       Date:  1973-09

2.  Precipitins to Klebsiella and other enterobacteria in the serum of patients with chronic respiratory disorders.

Authors:  M W Burns
Journal:  Lancet       Date:  1968-02-24       Impact factor: 79.321

3.  Haemophilus influenzae precipitins in the serum of patients with chronic bronchial disorders.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1967-02-18       Impact factor: 79.321

4.  The pattern of bacterial infection in bronchial diseases in Australia: a serological and bacteriological survey.

Authors:  M W Burns
Journal:  Med J Aust       Date:  1972-09-23       Impact factor: 7.738

5.  Precipitins to pneumococcal C-substance polysaccharide in the serum of patients with chronic bronchial disorders.

Authors:  M W Burns
Journal:  Lancet       Date:  1968-02-03       Impact factor: 79.321

6.  Bacterial precipitins in serum of patients with cystic fibrosis.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1968-02-10       Impact factor: 79.321

7.  Bacterial infection in cystic fibrosis.

Authors:  J R May; N C Herrick; D Thompson
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

8.  The course of chronic hemophilus bronchitis treated with massive doses of penicillin and penicillin combined with streptomycin.

Authors:  J W Jenne; F M MacDonald; E M Lapinski; N E Bratberg; W H Hall
Journal:  Am Rev Respir Dis       Date:  1970-06
  8 in total
  6 in total

1.  Perinatal infections caused by Haemophilus influenzae.

Authors:  S Nicholls; T D Yuille; R G Mitchell
Journal:  Arch Dis Child       Date:  1975-09       Impact factor: 3.791

2.  Purification of specific precipitinogen and extraction of endotoxin from Haemophilus influenzae.

Authors:  J C van der Zwan; J Dankert; K de Vries; N G Orie; H F Kauffman
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

3.  Bacterial precipitins and their immunoglobulin class in atopic asthma, non-atopic asthma, and chronic bronchitis.

Authors:  R J Davies; V C Holford-Strevens; I D Wells; J Pepys
Journal:  Thorax       Date:  1976-08       Impact factor: 9.139

4.  A study of the effects of 780SE on carbohydrate tolerance and plasma hormone and lipid profile in maturity-onset diabetes.

Authors:  A C Asmal; W P Leary
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

5.  Development of an immunoglobulin A-specific anti-Haemophilus influenzae antibody assay for detection of antibody in human mucosal secretions.

Authors:  S Yeung; G Pang; A W Cripps; R L Clancy
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

6.  Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine.

Authors:  R L Clancy; A W Cripps; A J Husband; D Buckley
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.